Sara Rattotti

10PUBLICATIONS
47CO-AUTHORS
Predictive and prognostic markersMicrobial geneticsAutoimmunityCardiovascular medicine and haematology not elsewhere classifiedImmunology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 31, 2026
Survival after first relapse in marginal zone lymphomas: Prospective data from the international observational NF10 study.

|Jun 15, 2023
Gut Microbiota and B Cell Receptor (BCR) Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Is Biodiversity Correlated with Clinical Response or Immune-Related Adverse Event Occurrence? A Cross-Sectional Study.

Valentina Zuccaro, Greta Petazzoni, Irene Mileto

|Apr 23, 2022
B-cell activating factor (BAFF), BAFF promoter and BAFF receptor allelic variants in hepatitis C virus related Cryoglobulinemic Vasculitis and Non-Hodgkin's Lymphoma.

Laura Gragnani, Serena Lorini, Silvia Marri

|Aug 02, 2020
Targeted next-generation sequencing reveals molecular heterogeneity in non-chronic lymphocytic leukemia clonal B-cell lymphocytosis.

Irene Defrancesco, Silvia Zibellini, Emanuela Boveri

|Aug 06, 2019
Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network.

Marzia Varettoni, Emanuela Boveri, Silvia Zibellini

|Jul 06, 2019
A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders.

Marzia Varettoni, Silvia Zibellini, Emanuela Boveri

Pageof 2

Frequent Collaborators

6 joint publications

Luca Arcaini

5 joint publications

Michele Merli

4 joint publications

Marzia Varettoni

2 joint publications

Marco Frigeni